CN110292129A - A kind of flax peptides beverage and preparation method thereof - Google Patents
A kind of flax peptides beverage and preparation method thereof Download PDFInfo
- Publication number
- CN110292129A CN110292129A CN201910632418.7A CN201910632418A CN110292129A CN 110292129 A CN110292129 A CN 110292129A CN 201910632418 A CN201910632418 A CN 201910632418A CN 110292129 A CN110292129 A CN 110292129A
- Authority
- CN
- China
- Prior art keywords
- flax
- peptides
- beverage
- linseed
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000004431 Linum usitatissimum Nutrition 0.000 title claims abstract description 56
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 52
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 47
- 235000013361 beverage Nutrition 0.000 title claims abstract description 46
- 241000208202 Linaceae Species 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 30
- 240000006240 Linum usitatissimum Species 0.000 claims abstract description 23
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 22
- 239000000944 linseed oil Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229920001184 polypeptide Polymers 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 14
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims abstract description 12
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000016709 nutrition Nutrition 0.000 claims abstract description 8
- 230000035764 nutrition Effects 0.000 claims abstract description 8
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 6
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 239000002562 thickening agent Substances 0.000 claims abstract description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 239000000839 emulsion Substances 0.000 claims description 16
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 10
- 229930003316 Vitamin D Natural products 0.000 claims description 10
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 10
- 229920000223 polyglycerol Polymers 0.000 claims description 10
- 229940013618 stevioside Drugs 0.000 claims description 10
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 10
- 235000019202 steviosides Nutrition 0.000 claims description 10
- 235000019166 vitamin D Nutrition 0.000 claims description 10
- 239000011710 vitamin D Substances 0.000 claims description 10
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 10
- 229940046008 vitamin d Drugs 0.000 claims description 10
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 239000011715 vitamin B12 Substances 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 235000010489 acacia gum Nutrition 0.000 claims description 7
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 4
- 229930003270 Vitamin B Natural products 0.000 claims description 4
- 239000003292 glue Substances 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000011720 vitamin B Substances 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 4
- 239000002023 wood Substances 0.000 claims description 4
- 235000016127 added sugars Nutrition 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 2
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- OQUFOZNPBIIJTN-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;sodium Chemical compound [Na].OC(=O)CC(O)(C(O)=O)CC(O)=O OQUFOZNPBIIJTN-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000004945 emulsification Methods 0.000 claims 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract description 30
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract description 15
- 229960004488 linolenic acid Drugs 0.000 abstract description 15
- 108091005804 Peptidases Proteins 0.000 abstract description 5
- 239000004365 Protease Substances 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 244000068988 Glycine max Species 0.000 abstract description 4
- 235000010469 Glycine max Nutrition 0.000 abstract description 4
- 102000035195 Peptidases Human genes 0.000 abstract description 4
- 235000013336 milk Nutrition 0.000 abstract description 4
- 239000008267 milk Substances 0.000 abstract description 4
- 210000004080 milk Anatomy 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 235000017060 Arachis glabrata Nutrition 0.000 abstract description 2
- 244000105624 Arachis hypogaea Species 0.000 abstract description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 abstract description 2
- 235000018262 Arachis monticola Nutrition 0.000 abstract description 2
- 240000007049 Juglans regia Species 0.000 abstract description 2
- 235000009496 Juglans regia Nutrition 0.000 abstract description 2
- 235000020510 functional beverage Nutrition 0.000 abstract description 2
- 235000020232 peanut Nutrition 0.000 abstract description 2
- -1 regulator Substances 0.000 abstract description 2
- 239000000758 substrate Substances 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 235000020234 walnut Nutrition 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 9
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 4
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 235000021055 solid food Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 241000863032 Trieres Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000003860 sleep quality Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010415 tidying Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The present invention relates to a kind of flax peptides beverages and preparation method thereof, using linseed polypeptide powder and linseed oil as primary raw material, add phosphatidylserine, nutrition fortifier, emulsifing thickener, regulator, antioxidant and water, by mixing, homogeneous, sterilizing, a kind of functional beverage rich in flax peptide, alpha-linolenic acid is prepared.The present invention is rich in peptides and alpha-linolenic acid, alpha-linolenic acid content is 2.0-3.0g in every 100mL beverage, and with beverage that walnut, peanut, soybean, linseed etc. are raw material preparation containing only protein, be free of or containing very micro alpha-linolenic acid, soya-bean milk class beverage is then free of alpha-linolenic acid at all;Furthermore, it is understood that beverage mouthfeel of the invention is good, it is convenient, it using linseed polypeptide powder as linolenic substrate, does not need through proteases for decomposing, but can directly be absorbed by the body, also eater's a large amount of time is saved, supplements necessary material in a manner of more convenient and fast for eater.
Description
Technical field
The present invention relates to dairy products, such as milk, butter, cheese;The substitute of milk or cheese;Its technical field prepared, it is special
It is not related to a kind of using flax peptide, linseed oil as flax peptides beverage of primary raw material and preparation method thereof.
Background technique
Scientific investigations showed that flax peptide (including other protein peptides) be its protein obtained through enzymatic hydrolysis by amino acid group
At segment or amino acid do not need proteases for decomposing, and be directly absorbed into cell by intestinal villi, show stronger life
Manage function.Linseed oil is rich in alpha-linolenic acid, also referred to as plant ω -3.To protection blood vessel, prevention of arterial hardening, pre- anti-cancer has important
Effect.Wherein there are also important functions: promoting brain development and the intellectual development of fetus and infant, brain cell is delayed to decline
Always, prevent senile dementia.In view of the importance of ω -3 pairs of human bodies, the World Health Organization (WHO) suggests at least taking in for each person every day
1.0g ω-3。
Chinese Soclety of Nutrition's investigation discovery, China are one of the country that ω -3 takes in wretched insufficiency for a long time, everyone daily ω -
The half of 3 insufficiency of intake suggestion amount, and in China's resident's diet, fatty acid proportion serious unbalance, ω -6 and ω -3
Ratio be (20~30): 1, with the World Health Organization (WHO) suggest (5~10): 1 is far apart, so influence China occupy
The body lipid metabolism of the people, the synthesis and immune function of bioactive substance, therefore produce and be rich in omega-3 polyunsaturated fatty acids
Product it is particularly important.
In the prior art, the conventional product rich in omega-3 polyunsaturated fatty acids is mostly solid food or solid beverage,
Since degree of absorption of each eater for omega-3 polyunsaturated fatty acids in solid food has differences.Meanwhile solid is drunk
Product also have the shortcomings that brew inconvenient (needing cup and boiled water).And it is very convenient to drink liquid beverage, and edible solid is drunk
Material is then brewed there is needs and a series of work for preparing, tidying up, and is not also suitable for society with fast rhythm now.
Summary of the invention
The present invention solves in the prior art, and the conventional product rich in omega-3 polyunsaturated fatty acids is mostly solid food
Or solid beverage, and eater is caused to have differences the degree of absorption of omega-3 polyunsaturated fatty acids in solid food, and
Edible solid beverage is not suitable for the social status quo of fast pace life now there is also inconvenience, and the present invention provides a kind of excellent
Flax peptides beverage of change and preparation method thereof.
The technical scheme adopted by the invention is that a kind of flax peptides beverage, the beverage by following parts by weight component
It matches: linseed polypeptide powder 5 ~ 10,20 ~ 40 parts of linseed oil, 0.5 ~ 1.5 part of phosphatidylserine, nutrition fortifier
0.02 ~ 0.1 part, 5.5 ~ 12.5 parts of emulsifing thickener, 18 ~ 30 parts of regulator, 0.2 ~ 0.5 part of antioxidant and water 500 ~ 1000
Part.
In the present invention, linseed polypeptide powder is digested after de-oiling by the linseed kernel to shell and is prepared, by difference point
The amino acid residue segment composition of son amount, main component are isoleucine, valine, methionine, arginine, aspartic acid and paddy
Propylhomoserin, being respectively provided with reduces cholesterol, anticancer, blood pressure lowering, immunological regulation and oxidation resistant function, living with high physiology
Property;The maximum difference of peptides and usual protein is that the former does not need protein (protease) decomposition, can directly be inhaled by body
It receives, the latter need to can just be absorbed by the body through proteases for decomposing.
In the present invention, linseed oil is obtained from shelling linseed kernel through supercritical extract, and alpha-linolenic acid content reaches 55%.
In the present invention, phosphatidylserine (PS), which has, improves brain cell excitability, brain tonic and intelligence development, prevention brain cell
The effect of aging and memory decline, humidification each other can be played by combining with omega -3.
Preferably, the nutrition fortifier includes vitamin B12And vitamin D.
In the present invention, vitamin B12Cellular nucleic acid metabolism is participated in, is the important element of hematopoiesis, vitamin B12Shortage it is easy
Cause brain cell and nerve damage.
In the present invention, vitamin D plays an important role to the absorption of calcium, and the children D that is deficient in vitamin causes skeleton development bad,
And the elderly D that is deficient in vitamin easily causes osteoporosis.
In the present invention, increase vitamin B12And the nutrition fortifier based on vitamin D, be due to both vitamins containing only
In animal food, D and vitamin B therefore the people being a vegetarian absolutely is deficient in vitamin12, need to be subject to help;The ratio of the two
Example is generally 1:1.
Preferably, the emulsifing thickener is one of flaxseed gum, Arabic gum and polyglycerol ester or a variety of.
In the present invention, flaxseed gum is a kind of naturally occurring emulsifying agent, thickener and stabilizer, and viscosity is high, emulsibility is strong, is stablized
Property a kind of high, while still water-soluble dietary fiber, have and promote proliferation of probiotics effect.
In the present invention, Arabic gum and polyglycerol ester then have the function of conventional emulsion thickening.
In the present invention, the ratio of flaxseed gum, Arabic gum and polyglycerol ester is generally 1:0.5-2:0.5-5.
Preferably, the regulator is one of stevioside, xylo-oligosaccharide and oligofructose or a variety of.
In the present invention, xylo-oligosaccharide and oligofructose category oligosaccharide kind have and promote proliferation of intestinal probiotics effect;Stevioside
It is a kind of natural sweetener proposed from sweet taste chrysanthemum.
In the present invention, the ratio of stevioside, xylo-oligosaccharide and oligofructose is generally 1:0.4-1.67:6-16.67.
Preferably, the regulator further includes sodium citrate.
In the present invention, pH value, and flavor adjustment are adjusted using sodium citrate.
Preferably, the antioxidant is vitamin E.
A kind of preparation method of flax peptides beverage, the preparation method comprises the following steps:
Step 1: taking the linseed polypeptide powder of predetermined amount to mix in proportion with water, emulsion A is stirred into high-speed mixer;
Step 2: taking the linseed oil, vitamin D and vitamin B of predetermined amount12, flaxseed gum, polyglycerol ester and Arab is added
Glue, the water for adding one times of linseed oil amount obtain flax oil emulsion B through high pressure homogenizer emulsifying homogeneous;
Step 3: emulsion A and flax oil emulsion B being mixed in proportion, phosphatidylserine, stevioside, oligomeric wood is added
Sugar, oligofructose and vitamin E, through high pressure homogenizer homogeneous;
In the present invention, homogenization pressure is 18-20 MPa.
Step 4: the pH value for the product that regulating step 3 obtains;
Step 5: it is filling, through high pressure sterilization, obtain flax peptides beverage product.
In the present invention, emulsion is filling with can, then through high pressure sterilization, 121 DEG C of autoclave temperature, and pressure
103.4 kPa, time 15-30 min.
Preferably, in the step 1, linseed polypeptide powder and water are mixed in the ratio of 1:30.
In the present invention, linseed polypeptide powder and water are mixed in the ratio of 1:30 and refer generally to weight ratio.
Preferably, in the step 3, the refinement degree of the emulsion after high pressure homogenizer homogeneous is 0.6-0.7 μm.
Preferably, in the step 4, the pH value of the product obtained by sodium citrate regulating step 3 to 7.1.
The present invention provides flax peptides beverages of a kind of optimization and preparation method thereof, with linseed polypeptide powder and linseed oil
For primary raw material, phosphatidylserine, nutrition fortifier, emulsifing thickener, regulator, antioxidant and water are added, by mixed
Conjunction, homogeneous, sterilizing prepare a kind of functional beverage rich in flax peptide, alpha-linolenic acid.
The present invention is rich in peptides and alpha-linolenic acid compared with other vegetable proteins and flax beverage, in every 100mL beverage,
Alpha-linolenic acid content is 2.0-3.0g, and is the beverage of raw material preparation with walnut, peanut, soybean, linseed etc., containing only albumen
Matter is free of alpha-linolenic acid, or containing very micro alpha-linolenic acid, in general alpha-linolenic acid content is only 0.1-0.2 g, soya-bean milk class
Beverage is then at all without alpha-linolenic acid;Furthermore, it is understood that beverage mouthfeel of the invention is good, and it is convenient, it is more using linseed
Gly-His-Lys are not needed as linolenic substrate through proteases for decomposing, but can be directly absorbed by the body, and are also saved edible
Person's a large amount of time supplements necessary material in a manner of more convenient and fast for eater.
Specific embodiment
To further appreciate that technical characteristic of the invention, detailed explain is carried out to the present invention combined with specific embodiments below
It states.Embodiment only has exemplary effect to the present invention, acts on without any restrictions.
Those skilled in the art makes any insubstantial modifications on the basis of the present invention, all should belong to guarantor of the invention
Protect range.
Embodiment 1
A kind of flax peptides beverage, is formed by the component proportion of following parts by weight: 5 parts of linseed polypeptide powder, 20 parts of linseed oil,
0.5 part of phosphatidylserine, 2.5 parts of flaxseed gum, 2.5 parts of Arabic gum, it is 0.5 part of polyglycerol ester, 1.5 parts of stevioside, oligomeric
1 part of xylose, 15 parts of oligofructose, 0.5 part of sodium citrate, 0.01 part of vitamin D, vitamin B120.01 part, vitamin E 0.2
Part and 500 parts of water.
A kind of preparation method of flax peptides beverage:
Step 1: taking the linseed polypeptide powder of predetermined amount to mix in proportion with water, emulsion A is stirred into high-speed mixer;
Step 2: taking the linseed oil, vitamin D and vitamin B of predetermined amount12, flaxseed gum, polyglycerol ester and Arab is added
Glue, the water for adding one times of linseed oil amount obtain flax oil emulsion B through high pressure homogenizer emulsifying homogeneous;
Step 3: emulsion A and flax oil emulsion B being mixed in proportion, phosphatidylserine, stevioside, oligomeric wood is added
Sugar, oligofructose and vitamin E, through high pressure homogenizer homogeneous;
Step 4: the pH value for the product that regulating step 3 obtains, such as 7.1;
Step 5: it is filling, through high pressure sterilization, obtain flax peptides beverage product.
Embodiment 2
A kind of flax peptides beverage, is formed by the component proportion of following parts by weight: 10 parts of linseed polypeptide powder, linseed oil 40
Part, 1.5 parts of phosphatidylserine, 5 parts of flaxseed gum, 5 parts of Arabic gum, 2.5 parts of polyglycerol ester, 2.5 parts of stevioside, oligomeric wood
Sugared 2.5 parts, 24 parts of oligofructose, 1 part of sodium citrate, 0.05 part of vitamin D, vitamin B120.05 part, 0.5 part of vitamin E
And 1000 parts of water.
The preparation method is the same as that of Example 1 for a kind of flax peptides beverage.
Embodiment 3
A kind of flax peptides beverage, is formed by the component proportion of following parts by weight: 8 parts of linseed polypeptide powder, 25 parts of linseed oil,
1 part of phosphatidylserine, 6 parts of flaxseed gum, 3 parts of Arabic gum, 3 parts of polyglycerol ester, 2 parts of stevioside, 2.5 parts of xylo-oligosaccharide,
22 parts of oligofructose, 1 part of sodium citrate, 0.04 part of vitamin D, vitamin B120.04 part, 0.3 part of vitamin E and water 900
Part.
The preparation method is the same as that of Example 1 for a kind of flax peptides beverage, wherein flax peptide and water are mixed in the ratio of 1:30.
ω -3 content is high in flax peptides beverage of the invention, and in every 100mL beverage, alpha-linolenic acid stable content is in 2.0-
3.0g, stability are good.
The present invention is pushed away in experimental stage expansion, randomly selects 120, crowd's sample, wherein 60 people of male, 60 people of women,
Age 20-25 years old, be white collar crowd, no heredity medication history, listless medical history;It is divided into experimental group 1, experimental group 2,3 and of experimental group
Control group, respectively includes 15 people of 15 people of boy student and schoolgirl, and experimental group 1, experimental group 2, experimental group 3 and control group take implementation respectively
Flax peptides beverage of example 1,2,3 and take existing linseed solid beverage.Instructions of taking: once a day, experimental group 1, reality
Test group 2, experimental group 3 directly take, control group is reconstituted with warm water and is taken, take three months, cooperate stablize sleeping time.Weekly
User's physical condition (sleep quality, constipation degree) and the state of mind are checked and recorded in detail.
After three months, this is tried out crowd at random and is not occurred body adverse reaction, summarizes to result data, number of results
It is readme according to including the sample state of mind, use feeling.
In experimental group 1, it is believed that mouthfeel is partially thick, meta-acid person accounts for 66.7%, remaining thinks to be subjected to mouthfeel;3.3% it is on probation
It is inconvenient (no to remind) that person thinks to take, remaining thinks convenient to take;There is 53.3% to think that physical condition is steady in crowd on probation at random
Fixed, the doubtful raising of immunity, sense of discomfort of staying up late is few, remaining crowd thinks no excessive difference.
In experimental group 2, it is believed that mouthfeel is partially thick, meta-acid person accounts for 6.7%, it is believed that mouthfeel is partially thick, inclined sweet tea person accounts for 40%, remaining is thought
To be subjected to mouthfeel;100% trier thinks convenient to take;Have in crowd on probation at random 56.7% think physical condition it is stable,
The doubtful raising of immunity, sense of discomfort of staying up late is few, remaining crowd thinks no excessive difference.
In experimental group 3, it is believed that the bad person of mouthfeel accounts for 10%, remaining thinks to be subjected to mouthfeel;100% trier thinks to take
With conveniently;There is 86.7% to think that physical condition is stable, the doubtful raising of immunity in crowd on probation at random, sense of discomfort of staying up late is few, remaining
Crowd thinks no excessive difference.
It is obtained by the investigation and analysis of three groups of experimental group entirety: thinking that sleep quality was greatly improved accounts for 69.7%,
It is remaining to think that improvement degree is smaller;Think that constipation degree was obviously improved accounts for 87.6% in all constipation crowds, remaining thinks to change
It is apt to unobvious;Think that energy was improved accounts for 75.6%, remaining thinks that change degree is smaller.
In control group, it is believed that mouthfeel is partially thick or partially dilute (water control improper) person accounts for 50%, remaining thinks to be subjected to mouth
Sense;73.3% trier thinks to take inconvenience, remaining thinks convenient to take;There is 46.7% to think body shape in crowd on probation at random
Condition is stable, the doubtful raising of immunity, and sense of discomfort of staying up late is few, remaining crowd thinks no excessive difference.
By experiment, the present invention has preferable mouthfeel really, eats enhanced convenience, plays raising to a certain extent
Sleep quality improves energy and improves constipation problem.With preferable promotional value.
Claims (10)
1. a kind of flax peptides beverage, it is characterised in that: the beverage is formed by the component proportion of following parts by weight: linseed is more
Gly-His-Lys 5 ~ 10,20 ~ 40 parts of linseed oil, 0.5 ~ 1.5 part of phosphatidylserine, 0.02 ~ 0.1 part of nutrition fortifier, emulsification thickening
5.5 ~ 12.5 parts of agent, 18 ~ 30 parts of regulator, 0.2 ~ 0.5 part of antioxidant and 500 ~ 1000 parts of water.
2. a kind of flax peptides beverage according to claim 1, it is characterised in that: the nutrition fortifier includes vitamin
B12And vitamin D.
3. a kind of flax peptides beverage according to claim 1, it is characterised in that: the emulsifing thickener is linseed
One of glue, Arabic gum and polyglycerol ester are a variety of.
4. a kind of flax peptides beverage according to claim 1, it is characterised in that: the regulator is stevioside, oligomeric
One of xylose and oligofructose are a variety of.
5. a kind of flax peptides beverage according to claim 3, it is characterised in that: the regulator further includes citric acid
Sodium.
6. a kind of flax peptides beverage according to claim 1, it is characterised in that: the antioxidant is vitamin E.
7. a kind of preparation method of flax peptides beverage as described in one of claim 1 ~ 6, it is characterised in that: the preparation side
Method the following steps are included:
Step 1: taking the linseed polypeptide powder of predetermined amount to mix in proportion with water, emulsion A is stirred into high-speed mixer;
Step 2: taking the linseed oil, vitamin D and vitamin B of predetermined amount12, flaxseed gum, polyglycerol ester and Arab is added
Glue, the water for adding one times of linseed oil amount obtain flax oil emulsion B through high pressure homogenizer emulsifying homogeneous;
Step 3: emulsion A and flax oil emulsion B being mixed in proportion, phosphatidylserine, stevioside, oligomeric wood is added
Sugar, oligofructose and vitamin E, through high pressure homogenizer homogeneous;
Step 4: the pH value for the product that regulating step 3 obtains;
Step 5: it is filling, through high pressure sterilization, obtain flax peptides beverage product.
8. a kind of preparation method of flax peptides beverage according to claim 7, it is characterised in that: sub- in the step 1
Numb seed polypeptide powder and water are mixed in the ratio of 1:30.
9. a kind of preparation method of flax peptides beverage according to claim 7, it is characterised in that: high in the step 3
The refinement degree of emulsion after pressing homogenizer homogeneous is 0.6-0.7 μm.
10. a kind of preparation method of flax peptides beverage according to claim 7, it is characterised in that: in the step 4,
The pH value of the product obtained by sodium citrate regulating step 3 is to 7.1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910632418.7A CN110292129A (en) | 2019-07-13 | 2019-07-13 | A kind of flax peptides beverage and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910632418.7A CN110292129A (en) | 2019-07-13 | 2019-07-13 | A kind of flax peptides beverage and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110292129A true CN110292129A (en) | 2019-10-01 |
Family
ID=68031082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910632418.7A Pending CN110292129A (en) | 2019-07-13 | 2019-07-13 | A kind of flax peptides beverage and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110292129A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105831532A (en) * | 2016-03-25 | 2016-08-10 | 黑龙江省科学院大庆分院 | Preparation method for flaxseed cake polypeptide beverage |
CN106689948A (en) * | 2016-11-30 | 2017-05-24 | 河北爱怡尚饮品有限公司 | Collagen composite linolenic acid beverage and preparation method thereof |
CN107557420A (en) * | 2017-08-22 | 2018-01-09 | 无锡初晨生物科技有限公司 | A kind of preparation method of flaxseed meal polypeptide |
CN108323685A (en) * | 2018-02-08 | 2018-07-27 | 王维义 | A kind of raising memory instant powder and preparation method thereof |
-
2019
- 2019-07-13 CN CN201910632418.7A patent/CN110292129A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105831532A (en) * | 2016-03-25 | 2016-08-10 | 黑龙江省科学院大庆分院 | Preparation method for flaxseed cake polypeptide beverage |
CN106689948A (en) * | 2016-11-30 | 2017-05-24 | 河北爱怡尚饮品有限公司 | Collagen composite linolenic acid beverage and preparation method thereof |
CN107557420A (en) * | 2017-08-22 | 2018-01-09 | 无锡初晨生物科技有限公司 | A kind of preparation method of flaxseed meal polypeptide |
CN108323685A (en) * | 2018-02-08 | 2018-07-27 | 王维义 | A kind of raising memory instant powder and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
邹演等: "亚麻籽粕制备多肽饮料的研究", 《食品工业》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101156679B (en) | Rice bran nutrition stock solution and its preparation method | |
CN101322513A (en) | Liquid state dairy food and producing method thereof | |
CN101292752A (en) | Chickpea soymilk nutritious beverage and preparation method thereof | |
CN101214051A (en) | Donkey-hide gelatin jujube beverage and preparation thereof | |
CN106259962A (en) | A kind of high calcium instant bean preparation method for diatery supplement nutriment | |
CN107801936A (en) | A kind of composition for being uniformly dispersed, promoting lactation and preparation method thereof | |
CN105768052A (en) | Health-care salad dressing and preparing method thereof | |
CN101642272A (en) | Millet drink and manufacturing method thereof | |
CN103988911A (en) | Black potato buffalo milk dairy product and preparation method thereof | |
KR19980025788A (en) | Lactic acid bacteria fermented products containing herbal extracts and preparation method thereof | |
CN101731352A (en) | Milk beverage with dietary function and preparation method thereof | |
CN105941779A (en) | Combined drink of maca, milk and coffee and preparation method of combined drink | |
RU2525338C2 (en) | Instant functional food product | |
KR20110101375A (en) | Functional beverage composition and manufacturing method thereof | |
CN107836526A (en) | A kind of feature sand rice compound bean milk and its production technology | |
CN104171259A (en) | Health-preserving ice cream and preparation method thereof | |
KR100955043B1 (en) | Powder composition of cake for weight loss and manufacturing method of cake using the same | |
CN110292129A (en) | A kind of flax peptides beverage and preparation method thereof | |
CN109452369A (en) | It is a kind of to receive cream and its preparation method and application containing milk powder | |
CN111616222A (en) | Egg white raw beverage formula and preparation method thereof | |
JP2001178413A (en) | Nutritional food | |
KR20190140152A (en) | Walnut cake with dried fruits and manufacturing method thereof | |
CN108174963A (en) | A kind of functional hard candy of stomach strengthening and digestion promoting and preparation method thereof | |
RU2709956C1 (en) | Alcohol-free beverage for iodine deficiency prevention | |
RU2376781C1 (en) | Revitalising food emulsion "krozam" and its production method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211130 Address after: 310030 Room 601, building 1, No. 2, Xiyuan 8th Road, Sandun Town, Xihu District, Hangzhou City, Zhejiang Province Applicant after: Zhongzhi (Zhejiang) flax Technology Development Co.,Ltd. Address before: 310012 room 2, unit 8, 49 Xihu District Road, Hangzhou, Zhejiang, 205. Applicant before: Wang Weiyi |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191001 |